ONT

ONT is in a Stage 2 advancing regime with a bullish Higher Highs & Higher Lows pattern signaling demand dominance and asymmetric upside. Price is tightly tracking above rising 9- and 20-day EMAs without exhaustion, favoring continuation participation. We recommend buying now for shallow pullbacks or breakouts near the EMA band. Key risks include overbought RSI, potential momentum fatigue, and overhead 50-day SMA resistance.

• ↑Real-time DNA sequencing adoption rising in healthcare and research.
• ↑Strong liquidity underpins operations and funds growth initiatives.
• ↓Negative profitability track record limits sustainable returns.